Get the Stockscreener App
6.45
2.71%
0.17
Generation Bio Co stock is traded at $6.45, with a volume of 78,231.
It is up +2.71% in the last 24 hours and up +51.05% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$6.28
Open:
$6.35
24h Volume:
78,231
Relative Volume:
0.24
Market Cap:
$43.44M
Revenue:
$21.23M
Net Income/Loss:
$-72.42M
P/E Ratio:
-0.9527
EPS:
-6.77
Net Cash Flow:
$-81.69M
1W Performance:
+2.54%
1M Performance:
+51.05%
6M Performance:
+5.70%
1Y Performance:
-74.40%
1-Day Range:
$6.28
$6.55
1-Week Range:
$5.94
$6.81
52-Week Range:
$3.004
$29.40
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
6.45 | 44.66M | 21.23M | -72.42M | -81.69M | -6.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Generation Bio price target raised to $10 from $9 at Canaccord - MSN
Advanced analytics toolkit walkthrough for Generation Bio Co.Portfolio Return Report & Verified Chart Pattern Trade Signals - Newser
Will Generation Bio Co. price bounce be sustainable2025 EndofYear Setup & Technical Pattern Based Signals - Newser
How sentiment analysis helps forecast Generation Bio Co.July 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Can swing trading help recover from Generation Bio Co. lossesQuarterly Trade Report & Expert Approved Momentum Ideas - Newser
Real time social sentiment graph for Generation Bio Co.Day Trade & Community Consensus Stock Picks - Newser
Is Generation Bio Co. still worth holding after the dipPortfolio Value Summary & Daily Entry Point Alerts - Newser
Can machine learning forecast Generation Bio Co. recoveryIPO Watch & Safe Capital Growth Trade Ideas - Newser
Sector ETF performance correlation with Generation Bio Co.July 2025 Recap & Accurate Buy Signal Notifications - Newser
Generation Bio Co. shares rise 2.41% premarket after Nitto Group's CFO outlines strategy to enhance corporate value. - AInvest
Using AI based signals to follow Generation Bio Co.2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Analyzing drawdowns of Generation Bio Co. with statistical toolsCEO Change & Verified Short-Term Plans - Newser
Should you hold or exit Generation Bio Co. nowJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Generation Bio (NASDAQ:GBIO) Given New $10.00 Price Target at Canaccord Genuity Group - Defense World
Generation Bio stock price target raised to $10 from $9 at Canaccord - Investing.com Canada
Generation Bio Co. shares rise 3.82% intraday after Samsung Biologics developed a next-generation IVT platform for mRNA production. - AInvest
Generation Bio’s SWOT analysis: ctLNP tech stock faces pivotal moment - Investing.com
Forecasting Generation Bio Co. price range with options dataWeekly Market Outlook & Expert Curated Trade Setups - Newser
Visual analytics tools that track Generation Bio Co. performanceJobs Report & Risk Controlled Swing Alerts - Newser
What momentum shifts mean for Generation Bio Co.2025 Bull vs Bear & High Accuracy Trade Signal Alerts - Newser
Regression analysis insights on Generation Bio Co. performanceDay Trade & Low Risk Investment Opportunities - Newser
What makes Generation Bio Co. stock attractive to long term investors2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Short Term Charts Align With Long Term Uptrend in Generation Bio Co.2025 Growth vs Value & Fast Exit/Entry Strategy Plans - sundaytimes.kr
Multi factor analysis applied to Generation Bio Co.Weekly Trade Analysis & Verified Trade Idea Suggestions - Newser
Using fundamentals and technicals on Generation Bio Co.Dollar Strength & Pattern Based Trade Signal System - Newser
Generation Bio Co. Could See a Relief Rally From SupportJuly 2025 Gainers & High Accuracy Trade Alerts - beatles.ru
Generation Bio Co. stock trend outlook and recovery pathWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
What institutional flow reveals about Generation Bio Co.2025 Performance Recap & Accurate Entry and Exit Point Alerts - Newser
Generation Bio Co. recovery potential after sell offQuarterly Portfolio Summary & Stepwise Trade Signal Implementation - Newser
Wedbush Brokers Reduce Earnings Estimates for Generation Bio - Defense World
Will Generation Bio Co. bounce back from current supportQuarterly Profit Summary & Risk Controlled Daily Plans - Newser
How to escape a deep drawdown in Generation Bio Co.Portfolio Performance Report & High Return Trade Opportunity Guides - Newser
Can Generation Bio Co. Rally Enough to Break EvenJuly 2025 Closing Moves & Verified Swing Trading Watchlists - news-j.co.kr
Building trade automation scripts for Generation Bio Co.Short Setup & Capital Efficiency Focused Strategies - Newser
Can Generation Bio Co. Bounce Back From Weekly LowBreakout Watch & Real-Time Volume Analysis - theviewers.co.kr
Generation Bio Co. Warns Stakeholders of Persistent Business Risks in 2024 Report - MSN
Generation Bio Co. shares fall 5.60% intraday amid sector update on biotechnology innovations. - AInvest
Fate Therapeutics, Generation Bio, and ORIC Pharmaceuticals Announce Workforce Reductions Amid Restructuring Efforts - geneonline.com
JMP Securities reiterates Market Perform rating on Generation Bio stock By Investing.com - Investing.com Canada
JMP Securities reiterates Market Perform rating on Generation Bio stock - Investing.com India
Why Generation Bio Co. stock attracts strong analyst attentionTrade Risk Assessment & AI Powered Market Entry Ideas - Newser
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates - MSN
Generation Bio Co (GBIO Stock: A Sea of Opportunity - investchronicle.com
Generation Bio Shares Surge Following Restructuring Plans, Q2 Results - MarketScreener
Generation Bio soars as it explores strategic alternatives - Seeking Alpha
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves - NewsBreak: Local News & Alerts
Generation Bio Co. stock prediction for this weekJuly 2025 Update & Low Drawdown Trading Techniques - Newser
Wedbush downgrades Generation Bio stock rating to Neutral amid restructuring - Investing.com Canada
Generation Bio Stock Surged 31% Pre-Market Today – What’s Going On? - Stocktwits
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Generation Bio Co Stock (GBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
| Howze Yalonda | CHIEF LEGAL OFFICER |
Oct 15 '24 |
Option Exercise |
2.42 |
3,347 |
8,100 |
15,169 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):